Alessandra Cesano is an accomplished leader in the biopharmaceutical industry, currently serving as an Advisor at General Catalyst since February 2025. In addition to this role, Alessandra holds multiple board positions at Zymeworks Inc., Summit Therapeutics, and Puma Biotechnology, all of which commenced between 2022 and 2024. As Chief Medical Officer at ESSA Pharmaceuticals since July 2019, Alessandra has also previously held key positions including CMO at NanoString Technologies and Cleave Biosciences. Earlier career milestones include serving as COO/CMO at Nodality Inc., and Vice President roles in Oncology and Clinical Development at Biogen Idec from 2006 to 2008.
This person is not in any teams
This person is not in any offices